264 related articles for article (PubMed ID: 33852248)
1. Oral Sarecycline for Treatment of Papulopustular Rosacea: Results of a Pilot Study of Effectiveness and Safety.
Rosso JQ; Draelos ZD; Effron C; Kircik LH
J Drugs Dermatol; 2021 Apr; 20(4):426-431. PubMed ID: 33852248
[TBL] [Abstract][Full Text] [Related]
2. Once-Daily Oral Sarecycline 1.5 mg/kg/day Is Effective for Moderate to Severe Acne Vulgaris: Results from Two Identically Designed, Phase 3, Randomized, Double-Blind Clinical Trials.
Moore A; Green LJ; Bruce S; Sadick N; Tschen E; Werschler P; Cook-Bolden FE; Dhawan SS; Forsha D; Gold MH; Guenthner S; Kempers SE; Kircik LH; Parish JL; Rendon MI; Rich P; Stein-Gold L; Tyring SK; Weiss RA; Nasir A; Schmitz C; Boodhoo TI; Kaoukhov A; Berk DR
J Drugs Dermatol; 2018 Sep; 17(9):987-996. PubMed ID: 30235387
[TBL] [Abstract][Full Text] [Related]
3. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea.
Mrowietz U; Kedem TH; Keynan R; Eini M; Tamarkin D; Rom D; Shirvan M
Am J Clin Dermatol; 2018 Jun; 19(3):427-436. PubMed ID: 29396702
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study.
Leyden JJ; Sniukiene V; Berk DR; Kaoukhov A
J Drugs Dermatol; 2018 Mar; 17(3):333-338. PubMed ID: 29537451
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J
J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea.
Webster G; Draelos ZD; Graber E; Lee MS; Dhawan S; Salman M; Magrath GN
Br J Dermatol; 2020 Sep; 183(3):471-479. PubMed ID: 31907924
[TBL] [Abstract][Full Text] [Related]
7. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
[TBL] [Abstract][Full Text] [Related]
9. DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety.
van der Linden MMD; van Ratingen AR; van Rappard DC; Nieuwenburg SA; Spuls PI
Br J Dermatol; 2017 Jun; 176(6):1465-1474. PubMed ID: 27797396
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
Del Rosso JQ
Cutis; 2010 Nov; 86(5 Suppl):16-25. PubMed ID: 21229827
[TBL] [Abstract][Full Text] [Related]
11. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Elewski BE; Fleischer AB; Pariser DM
Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
[TBL] [Abstract][Full Text] [Related]
12. An open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads).
Webster GF
Cutis; 2010 Nov; 86(5 Suppl):7-15. PubMed ID: 21229826
[TBL] [Abstract][Full Text] [Related]
13. Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials.
Gold LS; Del Rosso JQ; Kircik L; Bhatia ND; Hooper D; Nahm WK; Stuart I
J Am Acad Dermatol; 2020 May; 82(5):1166-1173. PubMed ID: 32004648
[TBL] [Abstract][Full Text] [Related]
14. Sarecycline Review.
Haidari W; Bruinsma R; Cardenas-de la Garza JA; Feldman SR
Ann Pharmacother; 2020 Feb; 54(2):164-170. PubMed ID: 31462063
[No Abstract] [Full Text] [Related]
15. An overview of sarecycline for the treatment of moderate-to-severe acne vulgaris.
Valente Duarte de Sousa IC
Expert Opin Pharmacother; 2021 Feb; 22(2):145-154. PubMed ID: 32924666
[TBL] [Abstract][Full Text] [Related]
16. Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial.
Taieb A; Ortonne JP; Ruzicka T; Roszkiewicz J; Berth-Jones J; Peirone MH; Jacovella J;
Br J Dermatol; 2015 Apr; 172(4):1103-10. PubMed ID: 25228137
[TBL] [Abstract][Full Text] [Related]
17. Management of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials.
Del Rosso JQ; Stein Gold L; Baldwin H; Harper JC; Zeichner J; Obagi S; Graber E; Jimenez X; Vicente FH; Grada A
J Drugs Dermatol; 2021 Jun; 20(6):634-640. PubMed ID: 34076386
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies.
Thiboutot D; Thieroff-Ekerdt R; Graupe K
J Am Acad Dermatol; 2003 Jun; 48(6):836-45. PubMed ID: 12789172
[TBL] [Abstract][Full Text] [Related]
19. Oral Tetracyclines and Acne: A Systematic Review for Dermatologists.
Armstrong AW; Hekmatjah J; Kircik LH
J Drugs Dermatol; 2020 Nov; 19(11):s6-s13. PubMed ID: 33196746
[TBL] [Abstract][Full Text] [Related]
20. Sarecycline: First Global Approval.
Deeks ED
Drugs; 2019 Feb; 79(3):325-329. PubMed ID: 30659422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
